Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1ย 091,51
-2,30
-0,21%
โ€”1ย 093,811ย 096,521ย 100,221ย 091,51โ€”โ€”
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
โ€”608,77608,77612,97608,77โ€”โ€”
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1ย 237,98
-16,83
-1,34%
โ€”1ย 254,811ย 253,011ย 253,871ย 226,33โ€”โ€”
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1ย 744,71
-16,40
-0,93%
โ€”1ย 761,111ย 764,271ย 766,881ย 744,71โ€”โ€”
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
โ€”642,58644,87648,48640,18โ€”โ€”
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
โ€”851,13855,66858,75845,56โ€”โ€”
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
โ€”217,98217,98218,65216,88โ€”โ€”
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3ย 260,69
+48,86
+1,52%
โ€”3ย 211,833ย 227,213ย 268,383ย 226,55โ€”โ€”
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
โ€”948,98948,58957,83941,97โ€”โ€”
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1ย 466,80
-7,72
-0,52%
โ€”1ย 474,521ย 479,031ย 481,041ย 466,80โ€”โ€”
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2ย 397,50
+5,38
+0,22%
โ€”2ย 392,122ย 396,952ย 421,222ย 382,32โ€”โ€”
HALO:NASDAQ
Halozyme Therapeutics, Inc.
63,96ย $
+0,47%
(+0,30) 1D
63,69ย $
-0,42% (-0,27)
After hours
Closed: 1 ีดีตีฝ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HALO...
Open
63,48ย $
High
64,31ย $
Low
62,38ย $
Mkt. cap
7,58ย ีดีฌึ€ีค
Volume
978,03ย ีฐีฆึ€
P/E ratio
25,01
52-wk high
82,22ย $
52-wk low
47,50ย $
EPS
2,56ย $
Beta
1,03
Shares outstanding
118,47ย ีดีฌีถ
No. of employees
423
News stories
From sources across the web
Stock Titan
Stock Titan
·
1 ึ…ึ€ ีกีผีกีป
Halozyme sets May 11 earnings release, call after market close
Yahoo Finance
Yahoo Finance
·
1 ึ…ึ€ ีกีผีกีป
Halozyme to Report First Quarter 2026 Financial and Operating Results
Minichart
Minichart
·
1 ึ…ึ€ ีกีผีกีป
Halozyme Therapeutics Appoints Darren Snellgrove as Chief Financial Officer in April 2026
Stock Titan
Stock Titan
·
2 ึ…ึ€ ีกีผีกีป
Johnson & Johnson finance veteran joins Halozyme as CFO on June 8
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
Headquartersีีกีถ ิดีซีฅีฃีธ, ิฟีกีฌีซึ†ีธีผีถีซีก, ี„ีซีกึีตีกีฌ ี†ีกีฐีกีถีฃีถีฅึ€
Sector-
Websitehalozyme.com
Next call 9 ึ…ึ€ีซึ
ีดีตีฝ 11, ีฅึ€ีฏ, 16:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (1,52 est.)USD
Revenue / Estimate
-/ (359,05ย ีดีฌีถ est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ีฉ. ีดึ€ีฟ
2025 ีฉ. ีฐีถีฝ
2025 ีฉ. ีฝีฅีบ
2025 ีฉ. ีคีฅีฏ
Revenue
264,86ย ีดีฌีถ
325,72ย ีดีฌีถ
354,26ย ีดีฌีถ
451,77ย ีดีฌีถ
Cost of goods sold
63,20ย ีดีฌีถ
46,36ย ีดีฌีถ
72,49ย ีดีฌีถ
110,67ย ีดีฌีถ
Cost of revenue
63,20ย ีดีฌีถ
46,36ย ีดีฌีถ
72,49ย ีดีฌีถ
110,67ย ีดีฌีถ
Research and development expenses
-
17,54ย ีดีฌีถ
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,36ย ีดีฌีถ
41,61ย ีดีฌีถ
46,09ย ีดีฌีถ
63,33ย ีดีฌีถ
Operating expense
60,12ย ีดีฌีถ
76,92ย ีดีฌีถ
63,85ย ีดีฌีถ
86,70ย ีดีฌีถ
Total operating expenses
123,33ย ีดีฌีถ
123,28ย ีดีฌีถ
136,34ย ีดีฌีถ
197,37ย ีดีฌีถ
Operating income
141,54ย ีดีฌีถ
202,44ย ีดีฌีถ
217,92ย ีดีฌีถ
254,40ย ีดีฌีถ
Other non operating income
-
6,89ย ีดีฌีถ
-
-
EBT including unusual items
143,83ย ีดีฌีถ
204,94ย ีดีฌีถ
218,96ย ีดีฌีถ
-100,85ย ีดีฌีถ
EBT excluding unusual items
142,12ย ีดีฌีถ
204,94ย ีดีฌีถ
218,96ย ีดีฌีถ
251,58ย ีดีฌีถ
Income tax expense
25,73ย ีดีฌีถ
39,78ย ีดีฌีถ
43,73ย ีดีฌีถ
40,74ย ีดีฌีถ
Effective tax rate
17,89%
19,41%
19,97%
-40,40%
Other operating expenses
-
-
-
-
Net income
118,10ย ีดีฌีถ
165,16ย ีดีฌีถ
175,22ย ีดีฌีถ
-141,59ย ีดีฌีถ
Net profit margin
44,59%
50,71%
49,46%
-31,34%
Earnings per share
1,11
1,54
1,72
-0,24
Interest and investment income
5,11ย ีดีฌีถ
-
5,33ย ีดีฌีถ
2,09ย ีดีฌีถ
Interest expense
-4,52ย ีดีฌีถ
-4,39ย ีดีฌีถ
-4,30ย ีดีฌีถ
-4,91ย ีดีฌีถ
Net interest expenses
584,00ย ีฐีฆึ€
-4,39ย ีดีฌีถ
1,04ย ีดีฌีถ
-2,82ย ีดีฌีถ
Depreciation and amortization charges
-
-
-
-
EBITDA
160,48ย ีดีฌีถ
221,44ย ีดีฌีถ
236,84ย ีดีฌีถ
279,08ย ีดีฌีถ
Gain or loss from assets sale
-
-
-
2,62ย ีดีฌีถ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer